epigallocatechin gallate has been researched along with Infections, Staphylococcal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, N; Hao, K; Liu, C; Liu, Z | 1 |
| Brito, M; Delgadinho, M; Mira, AR; Ponte, T; Ribeiro, E; Zeferino, AS | 1 |
| Chen, H; Chen, R; Cui, M; Dong, Z; Feng, Y; Li, Y; Liu, W; Sun, S; Wang, J; Ye, H; Zhang, Q; Zhang, Y; Zheng, T | 1 |
| Hu, C; Kong, Q; Lu, Y; Luo, R; Wang, Y; Wu, C; Zhang, B; Zhang, F | 1 |
| Chen, C; Deng, X; Pan, J; Wang, J; Zhou, Y | 1 |
| Faezizadeh, Z; Gharib, A; Godarzee, M | 1 |
| Ishida, I; Kohda, C; Miyaoka, H; Shimamura, T; Yanagawa, Y | 1 |
7 other study(ies) available for epigallocatechin gallate and Infections, Staphylococcal
| Article | Year |
|---|---|
Epigallocatechin gallate (EGCG) attenuates staphylococcal alpha-hemolysin (Hla)-induced NLRP3 inflammasome activation via ROS-MAPK pathways and EGCG-Hla interactions.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bacterial Proteins; Catechin; Disease Models, Animal; Hemolysin Proteins; Hemolysis; Humans; Inflammasomes; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; THP-1 Cells | 2021 |
Drug Resistance and Epigenetic Modulatory Potential of Epigallocatechin-3-Gallate Against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Catechin; Drug Resistance; Epigenesis, Genetic; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Co-assembled nanocomplexes comprising epigallocatechin gallate and berberine for enhanced antibacterial activity against multidrug resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Berberine; Catechin; Methicillin-Resistant Staphylococcus aureus; Mice; Nanocomposites; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Synergistic Chemical and Photodynamic Antimicrobial Therapy for Enhanced Wound Healing Mediated by Multifunctional Light-Responsive Nanoparticles.
Topics: Animals; Anti-Infective Agents; Catechin; Cell Line; Chlorophyllides; Delayed-Action Preparations; Escherichia coli; Magnesium; Mice; Nanoparticles; Photochemotherapy; Porphyrins; Rats; Staphylococcal Infections; Staphylococcus aureus; Wound Healing; Wound Infection | 2019 |
Epigallocatechin gallate can attenuate human alveolar epithelial cell injury induced by alpha-haemolysin.
Topics: A549 Cells; Alveolar Epithelial Cells; Bacterial Toxins; Catechin; Cell Line; Hemolysin Proteins; Hemolysis; Humans; Microbial Sensitivity Tests; Protein Multimerization; Staphylococcal Infections; Staphylococcus aureus; Virulence | 2018 |
Therapeutic efficacy of epigallocatechin gallate-loaded nanoliposomes against burn wound infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Burns; Catechin; Kidney; Liposomes; Liver; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Nanostructures; Skin; Spleen; Staphylococcal Infections; Wound Infection | 2013 |
Epigallocatechin gallate suppresses expression of receptor activator of NF-kappaB ligand (RANKL) in Staphylococcus aureus infection in osteoblast-like NRG cells.
Topics: Animals; Catechin; Cytokines; Mice; Osteoblasts; Protease Inhibitors; RANK Ligand; Staphylococcal Infections; Staphylococcus aureus | 2007 |